Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1005993220824
Reference14 articles.
1. Lee CG, McCormick B, Mazumdar M, Vetto B, Borgen PI: Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumours. Int J Rad Onc Biol Phys 23: 969–975, 1992
2. Calle EE, Martin IM, Thun MJ, Mircale HI, Heath CW Jr: Family history, age and risk of fatal breast cancer. Am J Epidemiol 138: 675–681, 1993
3. De La Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand J-C, Pouillart P, Magdelenat H, Fourquet A: Age as a prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039–1043, 1993
4. Iwaya K, Tsuda H, Hiraide H, Tanaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis in breast cancer. Jap J Cancer Res 82: 835–840, 1991
5. Isola J, Viskorpi T, Holli K, Kallioniemi O-P: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Nat Cancer Inst 84: 1109–1114, 1992
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Age-related Variation in Expression of Breast Cancer Tumour Markers in Iranian Patients;MIDDLE EAST J CANCER;2021
2. Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations;Diagnostic Pathology;2014-03-25
3. Is Tamoxifen Alone Adequate Therapy in Very Young Chinese Women with Operable Breast Cancer?;The Breast Journal;2012-01-11
4. Breast Cancer in Chinese Women Younger than Age 40: Are They Different from Their Older Counterparts?;World Journal of Surgery;2008-04-12
5. The Significance of c-erbB-2 Overexpression and p53 Expression in Patients With Axillary Lymph Node—Negative Breast Cancer: A Tissue Microarray Study;International Journal of Surgical Pathology;2007-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3